St. Jude Riata Lawsuit Funding Helping Plaintiffs Stay Solvent

Steve Cid | January 27th, 2014

Five product liability lawsuits against the manufacturer of the St. Jude Riata defibrillator leads have been cleared to go forward by a federal judge in the Central District of California. U.S. District Judge James V. Selna rejected the manufacturer’s argument that they shouldn’t be responsible for  injuries because the St.  Jude leads were FDA approved. The leads are the subject… Read more »

Lipitor Patients May Face Statute of Limitations Cut-Off

Jacky Gale | January 14th, 2014

Countless numbers of Lipitor patients could soon be dealing with the implications of a cut-off date for Lipitor litigation. Lawsuits are subject to statutes of limitations, which vary from state to state. However, in many states, patients who took Lipitor (atorvastatin) and developed diabetes may face additional legal hurdles when filing a lawsuit after February 2014. Potential plaintiffs who have… Read more »

Biomet Hip Bellwether Trials Expected to Begin June 2015

Laura Woods | January 6th, 2014

The first of five bellwether trials for the ongoing Biomet hip federal multidistrict litigation, currently pending in the Northern District of Indiana, is expected to begin in June 2015. Approximately 900 product liability lawsuits are currently pending under MDL 2391. The cases were consolidated to avoid duplicate discovery, prevent conflicting rulings, and to convenience all parties. All of the plaintiffs… Read more »

Granuflo Multidistrict Litigation May Face Delays

Staff Writer | December 31st, 2013

On December 16, a joint motion was filed by plaintiffs and defendants involved in the ongoing Granuflo multidistrict litigation.  Because the joint motion requested a delay, many plaintiffs who are waiting for relief from the court are now interested in Fresenius heart attack lawsuit funding information. Granuflo and Naturalyte were both manufactured by Fresenius Medical Care and administered in dialysis… Read more »

Tylenol Multidistrict Litigation Moves Forward with Status Conference

Jacky Gale | December 23rd, 2013

A status conference was recently held to discuss various issues related to the Tylenol multidistrict litigation (MDL) No. 2436. On December 17, 2013, the parties presented their arguments with regards to a pending Motion for Protective Order, which had been filed by the defendants, Johnson & Johnson. The defendants filed the motion in an attempt to avoid disclosing certain information,… Read more »